China’s anti-doping agency announced on Nov. 20, 2026, that former national team doubles specialist Zhou Haodong tested positive for exogenous testosterone metabolites in an out-of-competition sample collected on Sept. 12, 2025, and will serve a three-year ban through Nov. 3, 2028.
The positive test came more than eight months after Zhou announced his departure from the Chinese national team on Jan. 2, 2025, ending a ten-year tenure that began in 2016. His last international appearance for China was at the 2024 Hong Kong Open.
The ban clarifies why Zhou was absent from the 15th National Games in 2025, a question that had lingered since his retirement announcement.
Rise through the youth ranks
Born Feb. 20, 1998, in Ningbo, Zhejiang, Zhou joined the provincial team in 2010 and entered the national setup six years later, according to Sina.
Partnering with Han Chengkai, Zhou captured the boys’ doubles titles at both the Asian and World Junior Championships in 2016, completing a junior “double crown” after helping China win the mixed team events at those tournaments in 2015.
Senior breakthrough and world team titles
The pair broke through on the senior circuit in 2018, winning the French Open and reaching the China Open final, where they twice defeated the then-world No. 1 Indonesian duo Marcus Fernaldi Gideon and Kevin Sanjaya Sukamuljo.
Zhou earned two Sudirman Cup gold medals as part of China’s mixed team squad, in 2019 and 2021. He added a third world team title at the 2023 Asia Mixed Team Championships.
Partner changes and later career
After Han stepped away due to injury, Zhou rotated partners including He Jiting, Wang Chang and Tan Qiang. With Wang, he won the men’s doubles gold at the 2021 National Games. With Tan, he claimed the 2024 Ruichang Masters title and helped Zhejiang win the National Team Championships later that year.
Personal milestone and the doping case
Zhou shared wedding photos on social media in February 2025, a month after his national team exit. The CHINADA decision published in November 2026 revealed the adverse analytical finding from the September 2025 test, resulting in the three-year period of ineligibility backdated to the date of provisional suspension.